Aerpio Pharmaceuticals, Inc. (NASDAQ:ARPO)

About the company

Aerpio Pharmaceuticals Inc. is a biopharmaceutical company, which engages in the research and development of treatments for ocular diseases. The firm's product candidate is AKB-9778, a small molecule activator of the Tie2 pathway, which completed the Phase 2a clinical trial for the treatment of diabetic retinopathy. It also develops ARP-1536, a humanized monoclonal antibody that is in preclinical development stage for the treatment of diabetic vascular complications; and AKB-4924, a selective stabilizer of hypoxia-inducible factor-1 alpha, which has completed a single ascending dose clinical trial for the treatment of inflammatory bowel disease. The company was founded by Joseph H. Garder on November 16, 2007 and is headquartered in Cincinnati, OH.

Sector

Health Technology

Industry

Pharmaceuticals: Major

Employees

12

CEO

Joseph H. Gardner

Exchange

NASDAQ

Website

http://www.aerpio.com

$20.00M

Total Revenue

12

Employees

$52.48M

Market Capitalization

-2.78

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$M

Operating Margin (in %)

Total operating margin

$-11M

Net Margin (in %)

Total net margin

$-10M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Johnson & Johnson JNJ 377376.69 82729.00 6.06 21.99 20.75
Merck & Co., Inc. MRK 202149.48 48081.00 7.59 19.94 21.10
Pfizer Inc. PFE 194670.90 50660.00 2.95 12.32 31.17
Eli Lilly & Co. LLY 153205.02 23087.00 51.99 27.00 23.97
AbbVie, Inc. ABBV 146737.92 34057.00 -23.49 17.50 24.65
Bristol Myers Squibb Co. BMY 110414.38 31006.00 2.68 93.87 3.08
Repligen Corp. RGEN 6456.09 286.00 6.19 281.31 8.11
Reata Pharmaceuticals, Inc. RETA 4978.60 20.00 23.58 -16.01 -150.30
Nektar Therapeutics NKTR 4220.48 137.00 3.29 -9.19 -335.62
Biohaven Pharmaceutical Holding Co. Ltd. BHVN 3702.40 1.00 34.23 -5.66 None
Allakos, Inc. ALLK 3122.21 None 6.78 -33.38 None
Karuna Therapeutics, Inc. KRTX 2853.24 None 7.45 -70.35 None
ADC Therapeutics SA ADCT 2642.22 2.00 31.17 -22.65 None
OPKO Health, Inc. OPK 2289.84 891.00 1.63 -7.83 -32.92
Turning Point Therapeutics, Inc. TPTX 2259.00 None 6.80 -18.90 None
IGM Biosciences, Inc. IGMS 2244.09 None 9.89 -41.37 None
Apellis Pharmaceuticals, Inc. APLS 2175.36 None 9.61 -5.22 None
Ra Pharmaceuticals, Inc. RARX 2111.78 3.00 8.68 -20.78 -585.71
Springworks Therapeutics, Inc. SWTX 1743.65 None 5.66 -27.97 None
Principia Biopharma, Inc. PRNB 1568.00 30.00 5.58 -22.31 -242.01
Y-mAbs Therapeutics, Inc. YMAB 1551.78 None 9.51 -16.84 None
Zymeworks, Inc. ZYME 1511.16 26.00 3.14 -8.91 -629.37
Akcea Therapeutics, Inc. AKCA 1370.61 341.00 2.81 -48.72 -8.59
Kiniksa Pharmaceuticals Ltd. KNSA 1305.15 None 6.76 -10.79 None
Tricida, Inc. TCDA 1301.44 None 6.69 -6.16 None
Arcutis Biotherapeutics, Inc. ARQT 1184.37 None 5.05 -18.94 None
Odonate Therapeutics, Inc. ODT 1150.14 None 9.42 -10.22 None
Phibro Animal Health Corp. PAHC 1072.15 818.00 5.41 29.06 4.49
Athenex, Inc. ATNX 1070.16 123.00 6.56 -9.94 -87.86
Akero Therapeutics, Inc. AKRO 957.58 None 8.00 -18.87 None
Constellation Pharmaceuticals, Inc. CNST 925.12 None 4.35 -9.97 None
G1 Therapeutics, Inc. GTHX 818.52 1.00 3.54 -6.24 None
Gossamer Bio, Inc. GOSS 802.76 None 3.26 -4.04 None
Oric Pharmaceuticals, Inc. ORIC 800.80 None -8.69 -26.48 None
Phathom Pharmaceuticals, Inc. PHAT 789.50 None 4.38 -2.90 None
Aprea Therapeutics, Inc. APRE 769.86 None 6.81 -22.77 None
Quanterix Corp. QTRX 752.76 60.00 6.64 -17.21 -71.52
Krystal Biotech, Inc. KRYS 731.00 None 4.26 -35.25 None
Provention Bio, Inc. PRVB 669.94 None 10.60 -15.13 None
Applied Therapeutics, Inc. APLT 660.44 14.00 4.26 -13.40 -19.41
Provention Bio, Inc. PRVB 651.88 None 10.31 -14.72 None
Keros Therapeutics, Inc. KROS 644.40 8.00 -29.11 -30.34 -285.35
Amneal Pharmaceuticals, Inc. AMRX 619.24 1679.00 4.26 -2.84 -11.85
Arcturus Therapeutics Holdings, Inc. ARCT 605.28 19.00 56.10 -21.76 -151.34
Oyster Point Pharma, Inc. OYST 596.40 None 5.99 -10.36 None
Mirum Pharmaceuticals, Inc. MIRM 503.75 None 3.28 -7.44 None
SIGA Technologies, Inc. SIGA 480.11 19.00 5.37 -24.40 -94.00
Satsuma Pharmaceuticals, Inc. STSA 463.25 None 4.56 -12.73 None
Imara, Inc. IMRA 461.21 None 4.45 -13.11 None
Biospecifics Technologies Corp. BSTC 436.94 40.00 3.55 18.69 61.80
DURECT Corp. DRRX 416.64 28.00 32.00 -17.23 -82.94
Crinetics Pharmaceuticals, Inc. CRNX 414.72 1.00 5.24 -7.11 -447.78
Fulcrum Therapeutics, Inc. FULC 410.55 1.00 6.92 -5.95 None
89bio, Inc. ETNB 386.40 None 4.77 -5.99 None
Relmada Therapeutics, Inc. RLMD 385.02 0.00 5.74 -32.17 -877.66
Ocular Therapeutix, Inc. OCUL 383.04 6.00 -46.94 -4.18 None
Kala Pharmaceuticals, Inc. KALA 380.16 6.00 4.16 -4.14 None
TCR2 Therapeutics, Inc. TCRR 373.20 None 2.55 -37.02 None
Osmotica Pharmaceuticals Plc OSMT 361.80 232.00 2.75 -1.32 -115.44
Ovid Therapeutics, Inc. OVID 324.90 None 7.68 -4.98 None
Urovant Sciences Ltd. UROV 315.00 None -5.59 -2.18 None
Aeglea Biotherapeutics, Inc. AGLE 298.98 4.00 9.44 -3.73 -523.27
HOOKIPA Pharma, Inc. HOOK 282.88 13.00 2.56 -6.25 -333.02
IDEAYA Biosciences, Inc. IDYA 274.60 None 4.17 -6.30 None
AMAG Pharmaceuticals, Inc. AMAG 273.70 321.00 1.05 -0.74 -115.05
Lannett Co., Inc. LCI 270.56 542.00 0.92 -8.90 -5.77
Verrica Pharmaceuticals, Inc. VRCA 257.50 None 4.70 -8.44 None
Spero Therapeutics, Inc. SPRO 254.03 12.00 3.34 -3.12 -656.72
Gritstone Oncology, Inc. GRTS 236.88 4.00 2.12 -2.27 None
KalVista Pharmaceuticals, Inc. KALV 233.46 12.00 2.58 -7.21 -263.38
Kaleido Biosciences, Inc. KLDO 221.10 None 7.84 -3.02 None
Veru, Inc. VERU 211.90 39.00 7.09 -21.73 -25.53
LogicBio Therapeutics, Inc. LOGC 191.36 1.00 5.78 -4.50 None
Galera Therapeutics, Inc. GRTX 180.25 None 3.37 -2.74 None
Liquidia Technologies, Inc. LQDA 171.38 8.00 10.12 -3.48 -602.17
Sutro Biopharma, Inc. STRO 171.12 41.00 3.25 -2.81 -148.06
Avenue Therapeutics, Inc. ATXI 167.52 532.00 30.79 -11.51 26.69
Protara Therapeutics, Inc. TARA 166.14 None 2.50 -10.77 None
Evelo Biosciences, Inc. EVLO 160.96 None 4.12 -1.84 None
Evolus, Inc. EOLS 159.60 45.00 2.86 -1.57 -217.51
Cyclerion Therapeutics, Inc. CYCN 156.60 6.00 1.97 -1.51 None
Tyme Technologies, Inc. TYME 148.35 None 8.60 -6.79 None
Trevi Therapeutics, Inc. TRVI 137.07 None 2.91 -4.67 None
scPharmaceuticals, Inc. SCPH 136.04 119.00 3.48 -4.34 -27.05
Harrow Health, Inc. HROW 135.72 51.00 8.70 -5.49 -47.54
Lyra Therapeutics, Inc. LYRA 134.40 1.00 -1.14 -8.06 -491.16
Aquestive Therapeutics, Inc. AQST 131.88 49.00 -7.60 -1.88 -139.64
PhaseBio Pharmaceuticals, Inc. PHAS 127.31 2.00 2.36 -2.66 None
Mustang Bio, Inc. MBIO 122.40 None 2.86 -2.49 None
TFF Pharmaceuticals, Inc. TFFP 121.60 None 4.71 -3.14 None
NeuBase Therapeutics, Inc. NBSE 121.24 None 50.94 -2.71 None
Immunic, Inc. IMUX 117.40 None 3.45 -53.36 None
Ayala Pharmaceuticals, Inc. AYLA 116.40 3.00 -2.74 -5.64 -679.19
Eton Pharmaceuticals, Inc. ETON 99.36 1.00 10.82 -4.97 None
Milestone Pharmaceuticals, Inc. MIST 96.75 None 0.96 -1.55 None
Checkpoint Therapeutics, Inc. CKPT 79.60 2.00 6.86 -3.43 -949.53
Clearside Biomedical, Inc. CLSD 79.54 6.00 10.21 -4.51 -293.61
EyePoint Pharmaceuticals, Inc. EYPT 78.48 26.00 5.54 -1.60 -196.30
Xeris Pharmaceuticals, Inc. XERS 78.12 4.00 3.87 -0.60 None
Corvus Pharmaceuticals, Inc. CRVS 75.40 None 1.21 -1.60 None
Baudax Bio, Inc. BXRX 72.00 None -1.96 -1.03 None
Navidea Biopharmaceuticals, Inc. NAVB 68.34 1.00 -50.25 -6.18 -65.13
BiomX, Inc. PHGE 65.45 None 1.72 -1.53 None
Genprex, Inc. GNPX 59.85 None 5.08 -4.38 None
Assertio Therapeutics, Inc. ASRT 59.04 192.00 1.02 -0.36 -83.99
Aridis Pharmaceuticals, Inc. ARDS 56.97 1.00 -23.44 -1.95 -851.00
Aerpio Pharmaceuticals, Inc. ARPO 52.48 20.00 1.58 -2.78 -51.58
Menlo Therapeutics, Inc. MNLO 49.01 2.00 4.12 -0.52 -483.51
Eyenovia, Inc. EYEN 45.44 None 4.58 -2.22 None
Edesa Biotech, Inc. EDSA 44.82 0.00 6.38 -0.47 -395.23
Moleculin Biotech, Inc. MBRX 42.69 None 3.71 -4.64 None
Citius Pharmaceuticals, Inc. CTXR 36.45 None 2.70 -2.11 None
Akari Therapeutics Plc AKTX 36.18 None -33.50 -2.01 None
Oncternal Therapeutics, Inc. ONCT 35.75 3.00 4.58 -1.42 -225.89
Mannatech, Inc. MTEX 34.80 156.00 1.47 7.84 3.45
AgeX Therapeutics, Inc. AGE 33.78 2.00 -44.45 -2.78 -658.11
Allena Pharmaceuticals, Inc. ALNA 33.70 None 4.44 -0.78 None
CNS Pharmaceuticals, Inc. CNSP 33.12 None 5.75 -6.09 None
Aileron Therapeutics, Inc. ALRN 32.48 None 4.46 -1.22 None
Adamis Pharmaceuticals Corp. ADMP 31.90 22.00 1.22 -1.08 -140.33
Acer Therapeutics, Inc. ACER 31.20 3.00 2.28 -1.20 -274.69
Annovis Bio, Inc. ANVS 26.88 None 2.46 -21.33 None
Millendo Therapeutics, Inc. MLND 25.80 0.00 0.61 -0.55 None
Hoth Therapeutics, Inc. HOTH 25.00 None 6.94 -2.78 None
Spring Bank Pharmaceuticals, Inc. SBPH 23.20 0.00 0.88 -0.89 None
Akorn, Inc. AKRX 22.68 721.00 -1.20 -0.06 -55.64
Daré Bioscience, Inc. DARE 18.81 1.00 8.25 -1.13 None
ProPhase Labs, Inc. PRPH 16.80 9.00 1.52 -5.60 -31.15
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Novan, Inc. NOVN 14.21 5.00 -3.27 -0.45 -602.34
Adial Pharmaceuticals, Inc. ADIL 13.80 None 3.37 -1.82 None
Titan Pharmaceuticals, Inc. TTNP 12.00 4.00 5.00 -0.67 -437.91
PDS Biotechnology Corp. PDSB 11.69 None 1.29 -0.46 None
Novus Therapeutics, Inc. NVUS 7.39 None 0.63 -0.35 None
Brickell Biotech, Inc. BBI 5.05 5.00 1.66 -0.07 -432.19
BioStar Pharmaceuticals, Inc. BSPM 0.21 0.00 0.01 0.10 294.01

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Aerpio Pharmaceuticals, Inc. (ARPO) Outpaces Stock Market Gains: What You Should Know

7d ago, source: Nasdaq

In the latest trading session, Aerpio Pharmaceuticals, Inc. (ARPO) closed at $1.26, marking a +1.61% move from the previous ...

Is Aerpio Pharmaceuticals (ARPO) Outperforming Other Medical Stocks This Year?

7d ago, source: YAHOO!

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Aerpio Pharmaceuticals (ARPO) is a stock that can certainly grab ...

Aerpio Announces Initiation of 28-Day Phase 2 Razuprotafib Glaucoma Trial

12d ago, source: MarketWatch

CINCINNATI, June 24, Jun 24, 2020 (GLOBE NEWSWIRE via COMTEX) -- Aerpio Pharmaceuticals, Inc. ("Aerpio") (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate ...

Aerpio Announces Change to Virtual Format for its 2020 Annual Meeting of Stockholders due to COVID-19

28d ago, source: Benzinga.com

CINCINNATI, June 08, 2020 (GLOBE NEWSWIRE) -- Aerpio Pharmaceuticals, Inc. (the "Company") (NASDAQ:ARPO), today announced that, due to the public health and safety concerns related to the novel ...

Aerpio Hosting Key Opinion Leader Call on a Novel Mechanism for the Treatment of Glaucoma

29d ago, source: GlobeNewswire

June 08, 2020 09:00 ET | Source: Aerpio Pharmaceuticals, Inc. CINCINNATI, June 08, 2020 (GLOBE NEWSWIRE) -- Aerpio Pharmaceuticals, Inc. (“Aerpio”) (Nasdaq: ARPO ...

DelMar Pharma secures $500K loan to support advancement of VAL-083

12d ago, source: Seeking Alpha

DelMar Pharmaceuticals (DMPI +1.3%) received a $500K loan from the National Brain Tumor Society and the National Foundation for Cancer Research in order to support VAL-083's preparation for ...

Aerpio Pharmaceuticals, Inc. (ARPO) Outpaces Stock Market Gains: What You Should Know

7d ago, source: YAHOO!

In the latest trading session, Aerpio Pharmaceuticals, Inc. (ARPO) closed at $1.26, marking a +1.61% move from the previous day. This change outpaced the S&P 500's 1.47% gain on the day.



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.